Prescribing Errors and Pharmacist Interventions in Paediatric Primary Health Care in Saudi Arabia: A Mixed-Methods

Anwar A Alghamdi1,2, Wael Y Khawagi3, Abdullah A Alshehri3

  • 1Health Information Technology Department, The Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Insights

Paediatric prescribing errors are common in primary care, with dose-related mistakes being most frequent. Pharmacist interventions successfully prevented patient harm by identifying and resolving these medication safety issues.

Area of Science:

  • Pharmacy Practice
  • Paediatric Medication Safety
  • Health Services Research

Background:

  • Medication use in children presents unique challenges and risks of prescribing errors, especially in primary care.
  • Evidence on paediatric prescribing errors in Saudi Arabia is limited, necessitating local investigation.
  • This study addresses the gap by examining prescribing errors and pharmacist interventions in Saudi paediatric primary care.

Purpose of the Study:

  • To determine the prevalence and patterns of prescribing errors in paediatric primary care.
  • To characterize pharmacist-led interventions for resolving these errors.
  • To identify factors associated with prescribing errors in this population.

Main Methods:

  • A prospective, mixed-methods, cross-sectional study conducted over three months.
  • Systematic review of paediatric outpatient prescriptions by clinical pharmacists.
  • Validation and classification of errors by a multidisciplinary panel, with qualitative analysis of interventions.

Main Results:

  • A prescribing error rate of 26.1% was found in 545 paediatric prescriptions, with 145 individual errors identified.
  • Dose-related errors constituted the majority (68.3%), significantly associated with patient weight, number of medications, and diagnosis.
  • Most errors (93.0%) were intercepted before dispensing, with no patient harm reported; interventions involved clinician communication.

Conclusions:

  • Prescribing errors are frequent in paediatric primary care but largely preventable with robust safeguards.
  • Pharmacists are crucial in detecting and resolving errors, preventing potential patient harm.
  • Improving prescribing support and interprofessional collaboration can enhance paediatric medication safety.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
738